doi: 10.1007/s13300-018-0428-y 133 McCartneyFGleesonJPBraydenDJ
Discovery of a novel series of orally bioavailable and CNS penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) non-competitive antagonists based on a 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione core
Weight regain is the primary concern
Focus on whether the provider: Holds an appropriate and verifiable license Has experience with your health concerns Explains recommendations clearly Uses testing thoughtfully Discusses risks, limitations, and alternatives Coordinates with other members of your healthcare team Refers patients when care falls outside their expertise The providers complete qualifications matter more than the wording used to describe the practice
By engaging multiple incretin pathways simultaneously, it has become a subject of interest in metabolic and endocrine research